Related Experiment Videos
HMG domain proteins induce sharp bends in cisplatin-modified DNA
C S Chow1, J P Whitehead, S J Lippard
1Department of Chemistry, Massachusetts Institute of Technology, Cambridge 02139.
Biochemistry
|December 20, 1994
Summary
High mobility group (HMG) domain proteins bind to cisplatin-damaged DNA, causing significant DNA bending. This interaction is crucial for understanding DNA repair mechanisms and drug efficacy.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Cisplatin is a widely used anticancer drug that forms intrastrand cross-links in DNA.
- High mobility group (HMG) domain proteins are known to interact with DNA and influence its structure.
Purpose of the Study:
- To investigate the binding of HMG domain proteins to cisplatin-modified DNA.
- To determine the effect of HMG domain protein binding on the bending of platinated DNA.
Main Methods:
- Synthesis of circularly permuted linear DNA probes (approx. 100 bp) containing a specific cisplatin adduct.
- Gel electrophoresis mobility shift assays to assess protein-DNA binding affinities.
- Measurement of DNA bending angles induced by HMG domain protein binding.
Main Results:
- Six different HMG domain proteins (HMG1, mtTFA, Ixr1, HMG domains from HMG1, mSRY, and LEF-1) recognized platinated DNA with comparable affinities (Kd ~10^-6 to 10^-7 M).
- HMG domain proteins significantly increased the bending of platinated DNA compared to its absence.
- The bend loci were found to be centered near the platinum adduct, with variability in bend angles suggesting different specific protein-DNA contacts.
Conclusions:
- HMG domain proteins effectively bind to and bend cisplatin-damaged DNA.
- The study provides a versatile methodology for creating and analyzing modified DNA structures.